Shuttle Pharmaceuticals Stock Shares Owned By Insiders
| SHPH Stock | USD 4.14 0.28 6.33% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Shuttle Pharmaceuticals' long-term financial health and intrinsic value.
Shuttle | Shares Owned By Insiders | Build AI portfolio with Shuttle Stock |
Shuttle Pharmaceuticals Company Shares Owned By Insiders Analysis
Shuttle Pharmaceuticals' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Shuttle Pharmaceuticals Shares Owned By Insiders | 5.82 % |
Most of Shuttle Pharmaceuticals' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Shuttle Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Shuttle Shares Owned By Insiders Driver Correlations
Understanding the fundamental principles of building solid financial models for Shuttle Pharmaceuticals is extremely important. It helps to project a fair market value of Shuttle Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Shuttle Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Shuttle Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Shuttle Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 5.818% of Shuttle Pharmaceuticals are shares owned by insiders. This is 61.67% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The shares owned by insiders for all United States stocks is 42.34% higher than that of the company.
Shuttle Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Shuttle Pharmaceuticals' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Shuttle Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Shuttle Pharmaceuticals by comparing valuation metrics of similar companies.Shuttle Pharmaceuticals is currently under evaluation in shares owned by insiders category among its peers.
Shuttle Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Shuttle Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Shuttle Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Shuttle Fundamentals
| Return On Equity | -5.51 | ||||
| Return On Asset | -1.76 | ||||
| Current Valuation | 628.12 K | ||||
| Shares Outstanding | 1.07 M | ||||
| Shares Owned By Insiders | 5.82 % | ||||
| Shares Owned By Institutions | 5.67 % | ||||
| Number Of Shares Shorted | 16.05 K | ||||
| Price To Book | 1.31 X | ||||
| EBITDA | (7.78 M) | ||||
| Net Income | (9.14 M) | ||||
| Cash And Equivalents | 50.44 K | ||||
| Total Debt | 1.17 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 0.03 X | ||||
| Book Value Per Share | 3.37 X | ||||
| Cash Flow From Operations | (7.33 M) | ||||
| Short Ratio | 0.39 X | ||||
| Earnings Per Share | (46.34) X | ||||
| Beta | 0.42 | ||||
| Market Capitalization | 4.73 M | ||||
| Total Asset | 2.51 M | ||||
| Retained Earnings | (34.58 B) | ||||
| Working Capital | 677.15 K | ||||
| Net Asset | 2.51 M |
About Shuttle Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Shuttle Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shuttle Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shuttle Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| NOAH | Noah Holdings | |
| CIG | Companhia Energetica de | |
| BBVA | Banco Bilbao Viscaya | |
| ENIC | Enel Chile SA | |
| SBSW | Sibanye Gold Ltd |
Check out Shuttle Pharmaceuticals Piotroski F Score and Shuttle Pharmaceuticals Altman Z Score analysis. For more detail on how to invest in Shuttle Stock please use our How to Invest in Shuttle Pharmaceuticals guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shuttle Pharmaceuticals. If investors know Shuttle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shuttle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Shuttle Pharmaceuticals is measured differently than its book value, which is the value of Shuttle that is recorded on the company's balance sheet. Investors also form their own opinion of Shuttle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Shuttle Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shuttle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Shuttle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shuttle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shuttle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shuttle Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.